SDC1 and lung cancer: Hovewer, low cell surface syndecan-1 level is associated with a poor prognosis as demonstrated by immunohistochemistry in lung cancer (51), renal carcinomas (52), head and neck cancer (53), and in colorectal cancer (54, 55).